• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Wal­greens to go pri­vate in $10B deal

2 months ago
Deals
Health Tech

Mod­er­na stands by its Covid vac­cine IP af­ter de­ci­sion ax­ing two patents

2 months ago
Pharma
Coronavirus

Health­care is bull­ish on AI

2 months ago
Health Tech

Cor­den­Phar­ma’s €100M in­vest­ment top-up; Cy­ti­va to lay off 85 staffers

2 months ago
Manufacturing

Long­time biotech in­vestor Fra­zier Life Sci­ences is rais­ing its lat­est ven­ture fund

2 months ago
Financing
Startups

No­vo Nordisk’s rare dis­ease ‘com­pa­ny with­in a com­pa­ny’ has an open goal in sick­le cell

2 months ago
R&D

Lux­a's stem cell ther­a­py for dry AMD shows ear­ly promise

2 months ago
R&D
Cell/Gene Tx

Cor­rect­ed: Mer­ck KGaA’s mixed Phase 2 lu­pus re­sults; Zymeworks paus­es work on ADC

2 months ago
News Briefing

Mer­ck KGaA says ear­li­er moves to lo­cal­ize man­u­fac­tur­ing help ease Trump tar­iff im­pact 

2 months ago
China
Pharma

De­nali stops some work on ALS drug af­ter analy­sis showed no im­pact on key bio­mark­er

2 months ago
R&D

Live up­dates: Makary like­ly a lock for next FDA chief af­ter breezy Sen­ate hear­ing

2 months ago
People
Pharma

No news is good news? Mer­ck KGaA qui­et on po­ten­tial Spring­Works takeover

2 months ago
Deals
Pharma

No­vo Nordisk looks in­to start­ing GLP-1 drug tri­als for ad­dic­tion

2 months ago
R&D

ITM re­ports more Phase 3 ra­dio­phar­ma da­ta in chal­lenge to No­var­tis’ Lu­tathera

2 months ago
R&D

Judge grants new na­tion­wide block on NIH pay­ment cuts 

2 months ago
Pharma
FDA+

No­vo Nordisk will join le­gal row over FDA's re­moval of semaglu­tide from short­age list

2 months ago
Law

Bavar­i­an Nordic CEO says it can take years to move phar­ma man­u­fac­tur­ing to the US

2 months ago
Pharma
Manufacturing

Trump ad­min­is­tra­tion re­vers­es lease ter­mi­na­tion for ma­jor FDA qual­i­ty lab in St. Louis

2 months ago
FDA+

No­vo Nordisk slash­es We­govy price by near­ly two-thirds for cash-pay­ing pa­tients

2 months ago
Pharma
Marketing

Lil­ly, Pfiz­er in­vest in UK star­tup's seed round for neu­rode­gen­er­a­tion pro­tein de­graders

2 months ago
Financing
Startups

Bris­tol My­er­s' MyoKar­dia unit ends work with Ful­crum; ALX dis­clos­es lay­offs

2 months ago
News Briefing

FDA puts BioN­Tech’s malar­ia vac­cine on clin­i­cal hold

2 months ago
R&D
FDA+

Live up­dates: Trump NIH pick Bhat­tacharya sails through Sen­ate hear­ing, side­step­ping con­tro­ver­sy

2 months ago
People
Pharma

Up­dat­ed: Jazz to buy Chimerix to get brain tu­mor drug five months ahead of PDU­FA

2 months ago
Deals
Pharma
First page Previous page 32333435363738 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Confirm Profile

Endpoints News